JP2022506394A5 - - Google Patents

Info

Publication number
JP2022506394A5
JP2022506394A5 JP2021523740A JP2021523740A JP2022506394A5 JP 2022506394 A5 JP2022506394 A5 JP 2022506394A5 JP 2021523740 A JP2021523740 A JP 2021523740A JP 2021523740 A JP2021523740 A JP 2021523740A JP 2022506394 A5 JP2022506394 A5 JP 2022506394A5
Authority
JP
Japan
Prior art keywords
acetic acid
composition according
concentration
ppm
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021523740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506394A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/001231 external-priority patent/WO2020089693A1/en
Publication of JP2022506394A publication Critical patent/JP2022506394A/ja
Publication of JP2022506394A5 publication Critical patent/JP2022506394A5/ja
Pending legal-status Critical Current

Links

JP2021523740A 2018-11-02 2019-11-01 薬剤耐性を誘導せずにバイオフィルムを処置するための組成物 Pending JP2022506394A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862755104P 2018-11-02 2018-11-02
US62/755,104 2018-11-02
PCT/IB2019/001231 WO2020089693A1 (en) 2018-11-02 2019-11-01 Compositions for treating biofilms without inducing antimicrobial resistance

Publications (2)

Publication Number Publication Date
JP2022506394A JP2022506394A (ja) 2022-01-17
JP2022506394A5 true JP2022506394A5 (enExample) 2022-11-09

Family

ID=69165410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021523740A Pending JP2022506394A (ja) 2018-11-02 2019-11-01 薬剤耐性を誘導せずにバイオフィルムを処置するための組成物

Country Status (13)

Country Link
EP (1) EP3873450A1 (enExample)
JP (1) JP2022506394A (enExample)
KR (1) KR20220027799A (enExample)
CN (1) CN113747889A (enExample)
AU (1) AU2019371088A1 (enExample)
BR (1) BR112021008550A2 (enExample)
CA (1) CA3118187A1 (enExample)
CL (1) CL2021001141A1 (enExample)
EA (1) EA202191212A1 (enExample)
IL (1) IL282819A (enExample)
MX (1) MX2021005136A (enExample)
PH (1) PH12021551010A1 (enExample)
WO (1) WO2020089693A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675299B2 (en) 2012-02-17 2020-06-09 Wiab Water Innovation Ab Hand disinfectant
US11364262B2 (en) 2012-02-17 2022-06-21 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of skin trauma
US12115185B2 (en) 2012-02-17 2024-10-15 Wiab Water Innovation Ab Compositions of hypochlorous acid and methods of manufacture thereof
US12551501B2 (en) 2012-02-17 2026-02-17 Wiab Water Innovation Ab Compositions and methods for treating biofilms without inducing antimicrobial resistance
TR201807950T4 (tr) 2012-02-17 2018-06-21 Wiab Water Innovation Ab Hipokloröz asitin (hocı) bileşimleri ve onların imalatının yöntemleri.
US11357794B2 (en) 2012-02-17 2022-06-14 Wiab Wafer Innovation Ab Preparations for controlled-release of hypochlorous acid
KR20230145023A (ko) * 2020-07-07 2023-10-17 더블유아이에이비 워터 이노베이션 에이비 미생물 감염을 소독, 치료 및 예방하기 위한 조성물 및 방법
US12611425B2 (en) 2022-10-10 2026-04-28 Wiab Water Innovation Ab Compositions and methods for treatment and prevention of pathogens
EP4458343B1 (de) 2023-05-04 2025-04-09 Heraeus Medical GmbH Vorrichtung zur präparation und abgabe einer antiseptischen wundspüllösung
EP4506000A1 (de) 2023-08-08 2025-02-12 Heraeus Medical GmbH Antiseptisches kit und dessen verwendung
EP4585254A1 (de) 2024-01-09 2025-07-16 Heraeus Medical GmbH Wundspüllösung zur entfernung von biofilmen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113854A (en) 1977-01-10 1978-09-12 Minnesota Mining And Manufacturing Company Prophylactic treatment of mastitis
GB8730107D0 (en) 1987-12-24 1988-02-03 Diversey Corp Treatment of mastitis & applicator therefor
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5797872A (en) 1996-04-26 1998-08-25 Nippon Ozone Co., Ltd. Method of treating domestic animals such as cows for mastitis and apparatus for injecting ozone into breasts
US20010036482A1 (en) 1999-10-15 2001-11-01 Dale Lind Fredell Antimicrobial compositions for mastitis control
US20030235560A1 (en) 2000-05-12 2003-12-25 Harrison Richard J. Mastitis prevention
US6589591B1 (en) 2001-07-10 2003-07-08 Baylor College Of Medicine Method for treating medical devices using glycerol and an antimicrobial agent
US20040186528A1 (en) 2003-03-20 2004-09-23 Medtronic, Inc. Subcutaneous implantable medical devices with anti-microbial agents for chronic release
US8449916B1 (en) 2009-11-06 2013-05-28 Iowa State University Research Foundation, Inc. Antimicrobial compositions and methods
US11364262B2 (en) * 2012-02-17 2022-06-21 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of skin trauma
US11672825B2 (en) * 2012-02-17 2023-06-13 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care
US10675299B2 (en) 2012-02-17 2020-06-09 Wiab Water Innovation Ab Hand disinfectant
EP3557990A1 (en) * 2016-12-22 2019-10-30 WIAB Water Innovation AB Preparations for controlled-release of hypochlorous acid

Similar Documents

Publication Publication Date Title
JP2022506394A5 (enExample)
JP2022506384A5 (enExample)
Lee et al. Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
Ruiz-Linares et al. Antimicrobial activity of alexidine, chlorhexidine and cetrimide against Streptococcus mutans biofilm
AU2014225252B2 (en) Antimicrobial-antibiofilm compositions and methods of use thereof
US10244758B2 (en) Compositions comprising a germinant and an antimicrobial agent
US20150264935A1 (en) Semi-Fluidic Composition for Lubricating, Moisture Retaining, Disinfecting, Sterilizing and Method Using the Same
ES2549081T3 (es) Métodos y composiciones para el tratamiento de la infección o la colonización infecciosa del párpado, la superficie ocular, la piel o el oído
CN109497093A (zh) 一种消毒液
EP2654700A1 (en) Otic composition for companion animals
CN107412213B (zh) 一种多功能外用抗菌灭菌药剂及其制备方法
Gaonkar et al. In vivo efficacy of an alcohol-based surgical hand disinfectant containing a synergistic combination of ethylhexylglycerin and preservatives
JP2014503469A5 (enExample)
Kampf Antiseptic stewardship for skin antiseptics
RU2502259C1 (ru) Способ получения водорастворимого бактерицидного препарата
CN111328811B (zh) 一种低浓度酒精杀菌消毒液及其应用
Ismail et al. Silver nanoparticles and sodium hypochlorite inhibitory effects on biofilm produced by Pseudomonas aeruginosa from poultry farms
Nilforoushzadeh et al. Efficacy of adding topical honey-based hydroalcoholic extract Nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime
US20210401002A1 (en) Chemical sterilization of honey
JP2020502249A5 (enExample)
CN105709272A (zh) 一种用于创面治疗的新型生物抗菌敷料
CN107802799A (zh) 一种医用消毒液
CN103520217A (zh) 一种生物杀菌剂及其应用
Smitran et al. Carbapenem-resistant acinetobacter baumannii: biofilm-associated genes, biofilm-eradication potential of disinfectants, and biofilm-inhibitory effects of selenium nanoparticles. Microorganisms 2023; 11: 171